Clearside Biomedical
CLSD
CLSD was delisted on the 28th of November, 2025.
26 hedge funds and large institutions have $2.18M invested in Clearside Biomedical in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 23 closing their positions.
0.1% less ownership
Funds ownership: 0.81% → 0.7% (-0.1%)
41% less funds holding
Funds holding: 44 → 26 (-18)
71% less capital invested
Capital invested by funds: $7.51M → $2.18M (-$5.32M)
74% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 23
77% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
+$161K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$48.6K |
| 3 |
NMG
New Millennium Group
Sandy,
Utah
|
+$20.1K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$15.8K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$565 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$164K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$155K |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$106K |
| 4 |
BWM
Brown Wealth Management
Naperville,
Illinois
|
-$80K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$71.7K |
CLSD Hedge Fund Activity: Q3 2025 in Review
26 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q3 2025, worth a combined $2.18M — down 71% from $7.51M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of CLSD and 6 opened new positions — a net loss of 17 holders — while 13 trimmed existing stakes and 3 added.
The largest buyer was Apollon Wealth Management, opening a new position worth an estimated $161K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $164K sold.
- 26 institutional investors held Clearside Biomedical (CLSD) as of Q3 2025, down from 44 in Q2 2025.
- Funds reported $2.18M of Clearside Biomedical stock for Q3 2025, down 71% quarter-over-quarter.
- 6 funds opened new Clearside Biomedical positions in Q3 2025 and 23 closed out, a net change of -17 holders.
- The largest Clearside Biomedical buyer in Q3 2025 was Apollon Wealth Management, an estimated $161K added.
- The largest Clearside Biomedical seller in Q3 2025 was Bridgeway Capital Management, an estimated $164K sold.
Based on aggregated 13F filings for Q3 2025.